Tick Bite & TBE Protection
Tick-bite
Tick Bite & TBE Protection
Discover How to Help Protect Yourself From Tick-Borne Encephalitis
There’s no cure for TBE, but it may be prevented.1,2
TBE is a rare viral infection for which there is no cure1 Nor is there specific treatment for TBE, only management of symptoms.1 The World Health Organization (WHO) recommends vaccination as a method to help protect against the contraction of the TBE virus while traveling to endemic countries throughout Europe and Asia.3
Most people infected with the TBE virus will not experience symptoms.4 But, if they do, the symptoms usually appear in two phases.5
Phase 01
People experience flu-like symptoms, including muscle pain, headache, fatigue, and a high temperature.5
Some patients
may appear
asymptomatic for
2-10 days
following Phase 015
Phase 02
Only some people experience the second phase, with more serious symptoms similar to other causes of inflammation of the brain and spine or meningitis.5 These symptoms may include a high fever, headache, nausea, vomiting, and vertigo.5
disease
Depending on the sub-type
of virus
10-50%
of people may experience 
neurological symptoms.6
Help Protect Yourself
If you are traveling to a country* that is affected by TBE, following a few simple steps can help reduce the chances of being bitten by a tick.1,5,7,8
Use the following protection and prevention methods to minimize your risk7:
  1. Avoid heavily tick-infested areas of forest and woodland from spring until fall, where possible.
  2. Wear light-colored clothing including long-sleeved tops and long trousers tucked into socks.8
  3. Use effective insect repellent and tick repellent.8
  4. Check your body for ticks regularly.
  5. Remove ticks as soon as possible by using a pair of fine-tipped tweezers
TicoVac may be available for people traveling to endemic countries and will have extensive exposure to ticks based on their planned outdoor activities and itinerary.
​​​​​​​Talk to your healthcare provider or a pharmacist about tick bite treatment and the importance of getting vaccinated with TicoVac.

LEARN MORE ABOUT TICOVAC

* Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, China, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Italy, Japan, Kazakhstan, Kyrgyzstan, Latvia, Liechtenstein, Lithuania, Moldova, Mongolia, Netherlands, Norway, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, South Korea, Sweden, Switzerland, Tunisia, Ukraine, United Kingdom.7
find a ticovac

Actor portrayals

find a ticovac
Find TicoVac
​​​​​​Near You
The best place to get international travel health information specific to you and your travel plans is to contact your healthcare provider or pharmacist.
FIND TICOVAC
References
  1. Dobler G, Erber W, Bröker M, Schmitt HJ, eds. The TBE Book. 4th ed. Global Health Press; 2021.
  2. TicoVac (Tick-Borne Encephalitis Vaccine). Prescribing Information. New York, NY: Pfizer Inc. 2023.
  3. World Health Organization. Immunization, Vaccines and Biologicals. Tick-borne encephalitis. Accessed August 20, 2025. https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/tick-borne-encephalitis.
  4. Susan L. Hills and Carolyn V. Gould. Tickborne Encephalitis. Centers for Disease Control and Prevention. CDC Yellow Book: Health Information for International Travel. Accessed August 20, 2025. https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/tick-borne-encephalitis.html.
  5. Kaiser R. Tick-borne encephalitis. Infect Dis Clin North Am. 2008;22(3):561-575. doi:10.1016/j.idc.2008.03.013
  6. Centers for Disease Control and Prevention. Tick-borne Encephalitis (TBE) Virus. Clinical Signs and Symptoms of TBE. Accessed August 20, 2025. https://www.cdc.gov/tick-borne-encephalitis/hcp/clinical-signs/.
  7. Travel Health Pro. Diseases in Brief. Tick-borne encephalitis. Accessed August 20, 2025. https://travelhealthpro.org.uk/disease/173/tick-borne-encephalitis.
  8. Travel Health Pro. Insect and tick bite avoidance. Accessed August 20, 2025. https://travelhealthpro.org.uk/factsheet/38/insect-and-tick-bite-avoidance.

IMPORTANT SAFETY INFORMATION AND INDICATION

Important Safety Information
  • TicoVac® should not be given to anyone with a history of a severe allergic reaction after a previous dose of TicoVac.
  • TicoVac may not protect all individuals against TBE.
  • Some individuals with weakened immune systems may have a reduced immune response.
  • TicoVac contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases.
  • The most common adverse reactions in subjects 1 through 15 years of age who received TicoVac were local tenderness, local pain, headache, fever, and restlessness.
  • The most common adverse reactions in subjects 16 through 65 years of age who received TicoVac were local tenderness, local pain, fatigue, headache, and muscle pain.
  • Tell your healthcare provider if you are pregnant, or plan to become pregnant.
  • Ask your healthcare provider about the risks and benefits for TicoVac. Only a healthcare provider can decide if TicoVac is right for you.
Indication
  • TicoVac is a vaccine indicated for active immunization to prevent tick-borne encephalitis (TBE) and is approved for use in individuals 1 year of age and older.

You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1-800-822-7967.

Please see full prescribing information for TicoVac here.

IMPORTANT SAFETY INFORMATION AND INDICATION

Important Safety Information
  • TicoVac® should not be given to anyone with a history of a severe allergic reaction after a previous dose of TicoVac.
  • TicoVac may not protect all individuals against TBE.
  • Some individuals with weakened immune systems may have a reduced immune response.
  • TicoVac contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases.
  • The most common adverse reactions in subjects 1 through 15 years of age who received TicoVac were local tenderness, local pain, headache, fever, and restlessness.
  • The most common adverse reactions in subjects 16 through 65 years of age who received TicoVac were local tenderness, local pain, fatigue, headache, and muscle pain.
  • Tell your healthcare provider if you are pregnant, or plan to become pregnant.
  • Ask your healthcare provider about the risks and benefits for TicoVac. Only a healthcare provider can decide if TicoVac is right for you.
Indication
  • TicoVac is a vaccine indicated for active immunization to prevent tick-borne encephalitis (TBE) and is approved for use in individuals 1 year of age and older.

You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1-800-822-7967.

Please see full prescribing information for TicoVac here.

This site is intended only for U.S. residents. The products discussed in this site may have different product labeling in different countries.
The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider.
  • © 2025 Pfizer Inc.
  • All rights reserved.
  • Pfizer Inc. PO Box 29387, Mission, KS 66201
  • November 2025
  • PP-TCV-USA-0218
  • PP-TCV-USA-0135
  • PP-TCV-USA-0219